Guideline | Reference | Country | Language | Body | Target group | Date |
---|---|---|---|---|---|---|
ACR | USA | English | Medical Society, Radiology | BC [6], Stage I BC [9], BC in women at higher than average risk [10] | ||
ACS-ASCO | [11] | USA | English | Medical Society, Oncology | BC | Dec 2015 |
ASCO | [12] | USA | English | Medical Society, Oncology | Primary BC after curative treatment | Mar 2013 |
AHS | [13] | Canada | English | Governmental, Multidisciplinary | EBC after BCT | Oct 2015 |
BCMH-BCMA | [14] | Canada | English | Governmental/Medical Society, Multidisciplinary | DCIS/IBC ≥ 19 years old | Oct 2013 |
CAR | [15] | Canada | English | Medical Society, Radiology | BC | Oct 2012 |
CCMB | [16] | Canada | English | Governmental, Multidisciplinary | BC | Jan 2017 |
DKG-DGGG | [17] | Germany | German | Medical Society, Multidisciplinary | BC | Dec 2017 |
ESMO | [18] | Switzerland | English | Medical Society, Oncology | Primary BC | Sep 2015 |
GISMa-ICBR/SIRM | [4] | Italy | English | Medical Society, Radiology | Women with a previous history of breast cancer | Aug 2016 |
HAS | France | French | Governmental, Multidisciplinary | BC; BC after curative treatment | ||
KCE | [21] | Belgium | English | Governmental, Multidisciplinary | DCIS / Early IBC | Jul 2013 |
NABON-KIMS | [22] | Netherlands | English | Governmental/Medical Society, Multidisciplinary | BC (without BRCA 1/2) | Feb 2012 |
NBOCC | [23] | Australia | English | Governmental, Multidisciplinary | EBC after BCT | Mar 2010 |
NCCN | [24] | USA | English | Medical Society, Oncology | IBC | Mar 2018 |
NICE | [25] | UK | English | Governmental, Multidisciplinary | DCIS / Early IBC | Jul 2018 |
NZGG | [26] | New Zealand | English | Governmental, Multidisciplinary | EBC | Aug 2009 |
RCR | [27] | UK | English | Medical Society, Radiology | BC (without BRCA 1/2) | Jun 2013 |